As<unk>  is mainly metabolized by the liver enzyme CYP3A4, inhibitors of this enzyme (such as ketoconazole) are expected to increase its blood plasma concentrations. Conversely, CYP3A4 inducers lower plasma concentrations of<unk> , as has been shown in a study with rifampicin.
Abemaciclib
Trilaciclib
Cemiplimab
Nirsevimab
Regdanvimab
Lirentelimab
Obiltoxaximab
Sotrovimab